JCNRX
Price
$26.73
Change
-$0.73 (-2.66%)
Updated
Feb 21 closing price
Net Assets
5.08B
VEXMX
Price
$144.66
Change
-$4.58 (-3.07%)
Updated
Feb 21 closing price
Net Assets
116.7B
Ad is loading...

JCNRX vs VEXMX

Header iconJCNRX vs VEXMX Comparison
Open Charts JCNRX vs VEXMXBanner chart's image
Janus Henderson Contrarian R
Price$26.73
Change-$0.73 (-2.66%)
VolumeN/A
Net Assets5.08B
Vanguard Extended Market Index Investor
Price$144.66
Change-$4.58 (-3.07%)
VolumeN/A
Net Assets116.7B
JCNRX vs VEXMX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JCNRX vs. VEXMX commentary
Feb 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JCNRX is a Buy and VEXMX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
VEXMX has more cash in the bank: 117B vs. JCNRX (5.08B). VEXMX pays higher dividends than JCNRX: VEXMX (1.09) vs JCNRX (0.00). JCNRX was incepted earlier than VEXMX: JCNRX (16 years) vs VEXMX (37 years). JCNRX is a more actively managed with annual turnover of: 45.00 vs. VEXMX (11.00). JCNRX has a lower initial minimum investment than VEXMX: JCNRX (2500) vs VEXMX (3000). VEXMX annual gain was more profitable for investors over the last year : 20.99 vs. JCNRX (9.32). VEXMX return over 5 years is better than : 53.78 vs. JCNRX (28.98).
JCNRXVEXMXJCNRX / VEXMX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence16 years37 years-
Gain YTD5.7784.799120%
Front LoadN/AN/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets5.08B117B4%
Annual Yield % from dividends0.001.09-
Returns for 1 year9.3220.9944%
Returns for 3 years3.9424.5416%
Returns for 5 years28.9853.7854%
Returns for 10 years24.87124.9620%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HCSG10.780.11
+1.03%
Healthcare Services Group
ALVO11.70-0.02
-0.17%
Alvotech
LPTX0.48-0.01
-1.49%
Leap Therapeutics
EME424.64-10.21
-2.35%
EMCOR Group
OPRX6.19-0.38
-5.78%
OptimizeRx Corp